Cochlear | COH - Eigenkapital Und Reserven

Aktienkurs
185.00
Täglich Wechseln
-0.83 -0.45%
Monatlich
-26.05%
Jährlich
-32.82%
Q1 Prognose
191.63




Eigenkapital Und Reserven Veränderung Datum
Ansell USD 1.97B 10.2M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Fisher Paykel Healthcare NZD 1.99B 95.8M 2025-12
Healius AUD 1.03B 13.9M 2024-12
Integral Diagnostics AUD 301.71M 1.33M 2024-06
Mayne Pharma AUD 454.19M 93.58M 2024-06
Mesoblast USD 574.68M 22.76M 2025-12
Monash IVF AUD 253.91M 3.49M 2025-12
Nanosonics AUD 219.69M 9.78M 2025-12
Polynovo AUD 72.12M 3.07M 2024-06
Ramsay Health Care AUD 4.79B 916.1M 2025-12
Regis Healthcare AUD -29.95M 13.22M 2025-12
ResMed USD 6.32B 199.62M 2025-12
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Somnomed AUD 22.4M 2.61M 2023-06
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12